Breast cancer in premenopausal and postmenopausal women: clinicopathological findings and survival outcomes from a large registry-based cohort in Southern Iran

OBJECTIVE: To compare clinicopathological characteristics, treatment patterns, and survival outcomes between premenopausal and postmenopausal women with breast cancer in Iran. METHODS: This retrospective cohort study included 6,930 women aged ≥18 years diagnosed with breast cancer between 2014 and 2022 from the Shiraz Breast Cancer Registry. Patients were stratified by menopausal status. Clinicopathological features, tumor receptor status, and treatment modalities were compared. Five-year overall survival (OS) and disease-free survival (DFS) were estimated using Kaplan-Meier methods and evaluated with multivariable Cox proportional hazards models. RESULTS: Premenopausal women more frequently presented with aggressive tumor features, including larger tumor size, multifocality, necrosis, and adverse pathologic characteristics (all P<0.01). Postmenopausal patients had a higher prevalence of estrogen receptor-positive tumors (P=0.003) and more commonly received hormone therapy (P<0.001). Five-year OS was comparable between groups (96.1% vs. 96.0%, P=0.981), whereas DFS was higher in postmenopausal women (90.1% vs. 87.2%, P=0.030). In multivariable analysis, postmenopausal status (HR 0.49, 95% CI: 0.27-0.90) and hormone therapy (HR 0.43, 95% CI: 0.29-0.64) were independently associated with improved OS, whereas high tumor grade, concurrent lymphovascular and perineural invasion, and neoadjuvant chemotherapy were associated with poorer OS and DFS. CONCLUSIONS: Menopausal status was associated with distinct tumor biology, clinicopathological features, and treatment patterns in breast cancer, with premenopausal patients showing more aggressive disease. Although menopausal status showed some association with survival outcomes, its effect appeared largely driven by age and underlying tumor characteristics, suggesting limited independent prognostic value.

Authors

Institutions

Publication Details

Journal
Menopause The Journal of The North American Menopause Society
Published
2026-11-17
DOI
https://doi.org/10.1097/gme.0000000000002919
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Breast cancer in premenopausal and postmenopausal women: clinicopathological findings and survival outcomes from a large registry-based cohort in Southern Iran

Majid Akrami, Masoumeh Ghoddusi Johari‬, Aida Bazrgar, Arshin Ghaedi et al.
2 links
Menopause The Journal of The North American Menopause Society
Breast Cancer Treatment Studies
article

Breast cancer in premenopausal and postmenopausal women: clinicopathological findings and survival outcomes from a large registry-based cohort in Southern Iran

Majid Akrami, Masoumeh Ghoddusi Johari‬, Aida Bazrgar, Arshin Ghaedi, Amirhossein Mallahi, Abdol Rasoul Talei, Sedigheh Tahmasebi
article en

Abstract

OBJECTIVE: To compare clinicopathological characteristics, treatment patterns, and survival outcomes between premenopausal and postmenopausal women with breast cancer in Iran. METHODS: This retrospective cohort study included 6,930 women aged ≥18 years diagnosed with breast cancer between 2014 and 2022 from the Shiraz Breast Cancer Registry. Patients were stratified by menopausal status. Clinicopathological features, tumor receptor status, and treatment modalities were compared. Five-year overall survival (OS) and disease-free survival (DFS) were estimated using Kaplan-Meier methods and evaluated with multivariable Cox proportional hazards models. RESULTS: Premenopausal women more frequently presented with aggressive tumor features, including larger tumor size, multifocality, necrosis, and adverse pathologic characteristics (all P<0.01). Postmenopausal patients had a higher prevalence of estrogen receptor-positive tumors (P=0.003) and more commonly received hormone therapy (P<0.001). Five-year OS was comparable between groups (96.1% vs. 96.0%, P=0.981), whereas DFS was higher in postmenopausal women (90.1% vs. 87.2%, P=0.030). In multivariable analysis, postmenopausal status (HR 0.49, 95% CI: 0.27-0.90) and hormone therapy (HR 0.43, 95% CI: 0.29-0.64) were independently associated with improved OS, whereas high tumor grade, concurrent lymphovascular and perineural invasion, and neoadjuvant chemotherapy were associated with poorer OS and DFS. CONCLUSIONS: Menopausal status was associated with distinct tumor biology, clinicopathological features, and treatment patterns in breast cancer, with premenopausal patients showing more aggressive disease. Although menopausal status showed some association with survival outcomes, its effect appeared largely driven by age and underlying tumor characteristics, suggesting limited independent prognostic value.

Menopause The Journal of The North American Menopause Society
Shiraz University (IR), Shiraz University of Medical Sciences (IR)
Good health and well-being
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon